The Bristol Myers Squibb 2021 Golden Ticket Contest is a competition for the award of two Golden Tickets.
A Golden Ticket to LabCentral in Cambridge, MA covers the cost of one 6-ft lab bench and one resident scientist fee for one year for a promising life science start-up. The Contest will award a total of two Golden Tickets in 2021 to the one or two companies that best meet the judging criteria of the Contest, including that they are engaged in therapeutic research in the fields of oncology, hematology, immunology, cardiovascular disease, neuroscience or fibrotic diseases; or pursuing research in novel target identification, drug delivery, discovery technology platforms or translational R&D.
LabCentral provides fully equipped, permitted and supported lab space for biomedical research, plus programming and unmatched networking opportunities to help startups advance their science and build their companies. Visit: http://labcentral.org/facilities-services/ to learn more.
Applications for the Contest are being accepted now through August 17, 2021. Finalists will participate in a Virtual Pitch Event with the Bristol Myers Squibb Cambridge community. Winners will be announced following the Pitch Event, which will be on or around October 13.
To apply:
1) Apply at BMS site: https://www.surveymonkey.com/r/BMS_LabCentral
2) Submit here and we'll try to to help you get status on your application.
Disclaimer: MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.